Post mortem molecularly defined familial hypercholesterolemia and sudden cardiac death of young men

Forensic Science International

Volumn 106, Issue 2, 1999, Pages 87-92

  Vuorio, A F ^a   Kontula, K ^a   Turtola, H ^b   Sajantila, A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NORTH KARELIA CENTRAL HOSPITAL   (Finland)

Author keywords

Atherosclerosis; DNA; Familial hypercholesterolemia; Post mortem; Sudden death

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; FAMILIAL HYPERCHOLESTEROLEMIA; FINLAND; FOUNDER EFFECT; GENE MUTATION; HEART INFARCTION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MALE; PREVALENCE; PRIORITY JOURNAL; RECEPTOR GENE; SUDDEN DEATH;

EID: 0032713555     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(99)00149-8     Document Type: Article

References (13)

1. Goldstein J.L., Hobbs H.H., Brown M.S. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. 7th ed The Metabolic and Molecular Basis of Inherited Disease. 1995;1981-2030 McGraw-Hill, New York.
2. Vuorio A.F., Turtola H., Piilahti K.-M., Repo P., Kanninen T., Kontula K. Familial hypercholesterolemia in the Finnish North Karelia: a molecular, clinical and genealogical study. Arterioscler. Thromb. Vasc. Biol. 17:1997;3127-3138.
3. Leadbeatter S., Stansbie D. Postmortem diagnosis of familial hypercholesterolemia. Br. Med. J. 289:1984;1656.
4. Koivisto P.V.I., Koivisto U.M., Miettinen T.A., Kontula K. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels. Arterioscler. Thromb. 12:1992;584-592.
5. Schuster H., Luft F.C. Clinical criteria versus DNA diagnosis in heterozygous familial hypercholesterolemia. Is molecular diagnosis superior to clinical diagnosis? Arterioscler. Thromb. Vasc. Biol. 18:1998;331-332.
6. Aalto-Setälä K., Helve E., Kovanen P.T., Kontula K. Finnish type of low density lipoprotein receptor mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype. J. Clin. Invest. 84:1989;305-307.
7. Koivisto U.M., Turtola H., Aalto-Setälä K., Top B., Frants R.R., Kontula K. The familial hypercholesterolemia (FH) North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland. J. Clin. Invest. 90:1992;219-228.
8. Koivisto U.M., Viikari J.S., Kontula K. Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-asp and Leu380-His) and eight rare mutations of the LDL receptor gene. Am. J. Hum. Genet. 57:1995;789-797.
9. Lahti R.A., Sarna S., Penttilä A. Exploitation of autopsy in determining natural cause of death: trends in Finland with special reference to the diagnostics of ischemic heart disease and cerebrovascular diseases in middle-aged males, 1974-1993. Forensic Sci. Int. 91:1998;109-121.
10. Vuorio A.F., Paulin L., Turtola H., Kontula K. Deletions of the low density lipoprotein receptor gene underlying familial hypercholesterolaemia: screening by polymerase chain reaction using pooled DNA and blood samples. Mol Cell Probes. 11:1997;65-70.
11. Koivisto U.M., Hämäläinen L., Taskinen M.-R., Kettunen K., Kontula K. Prevalence of familial hypercholesterolemia among young North Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction. J. Lipid Res. 34:1993;269-277.
12. Miettinen T.A., Gylling H. Mortality and cholesterol metabolism in familial hypercholesterolemia. Arteriosclerosis. 8:1988;163-167.
13. Mortality in treated heterozygous familial hypercholesterolaemia; implications for clinical management. Atherosclerosis. 142:1999;105-112.